Quantcast
Last updated on April 23, 2014 at 13:09 EDT

Latest Drugs Stories

2014-01-15 08:27:54

Game Can Support Teacher, Parent Approach to Drug Facts Week January 27 DUBLIN, Ohio, Jan. 15, 2014 /PRNewswire/ -- In its newest educational program, the Generation Rx Initiative mixes online learning with video games to promote learning about the dangers of prescription drug misuse and abuse. (Photo: http://photos.prnewswire.com/prnh/20140115/CL46381 )(Logo: http://photos.prnewswire.com/prnh/20130410/MM91761 ) The game can easily be integrated into parents' and teachers' National...

2014-01-14 23:05:07

In 2013, 850 users saved $45,000 off their prescription medication costs. The savings were realized through Mobile Health’s prescription discount card program offered free. New York, NY (PRWEB) January 14, 2014 An end of year report shows that Mobile Health’s prescription discount card program saved users over $45,000 in 2013. The discount applies to most generic and brand name prescriptions sold at pharmacies nationwide. Since the cards are pre-activated and do not require...

2014-01-14 12:27:14

20% of Hospitals Now Investing in Closed System Transfer Devices to Prevent Exposure to Hazardous Drugs PORT WASHINGTON, New York, January 14, 2014 /PRNewswire/ -- Equashield (http://www.equashield.com [ \\lonpivdocs\ari\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.Outlook\ZS150YTY\www.equashield.com ]), the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, today announced that it has achieved 60% year-over-year sales growth for...

2014-01-13 16:25:02

SCRANTON, Pa., Jan. 13, 2014 /PRNewswire-USNewswire/ -- Department of Drug and Alcohol Programs Secretary Gary Tennis today announced that the department is now offering an interactive map on its website that plots the locations of hundreds of prescription drug take-back boxes statewide. The new interactive map was announced during a visit to the Lackawanna County Courthouse where one of the boxes associated with Governor Corbett's Healthy Pennsylvania drug take-back initiative was...

2014-01-13 12:23:55

Multi-year partnership includes a donation to Phoenix Suns Charities through use of the Free Prescription Discount Card Administered by Watertree Health PHOENIX, Jan. 13, 2014 /PRNewswire/ -- The Phoenix Suns and Phoenix Mercury today announced a new multi-year partnership with Watertree Health, a leading provider of free prescription discount cards, with a focus on finding solutions to the rising cost of prescription medicines. (Logo:...

2014-01-13 08:30:13

Topline Data Will Be Presented at Biotech Showcase HEIDELBERG, Germany, Jan. 13, 2014 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company, announced today the successful completion of its phase II proof-of-concept trial with APG101 in patients with recurrent glioblastoma. All endpoints of the randomized controlled trial that compared the efficacy and safety of a combination therapy of APG101 and radiotherapy versus radiotherapy alone were achieved or...

2014-01-13 08:26:50

To Expand Clinical Trial for Advanced Ovarian Clear Cell Carcinoma ROCKVILLE, Md., Jan. 13, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of diseases, announced today that it has moved to expand its Phase 2 clinical trial for its drug candidate ENMD-2076 in advanced ovarian clear cell carcinoma (OCCC) with the submission of a new drug global clinical trial application with China's Food and Drug...

2014-01-09 23:20:23

The Biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. (PRWEB) January 09, 2014 The “Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018”, provides a detailed overview of the major...

2014-01-07 13:50:07

The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient's share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina. Using data from health plan claims for the anti-cancer drug imatinib filed between 2002 to 2011, Stacie B. Dusetzina, PhD, research professor at the UNC School of Medicine and Gillings School...

2014-01-07 08:32:13

HEIDELBERG, Germany, Jan. 7, 2014 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company, announced today that Thomas Hoeger, Ph.D., Chief Executive Officer, will present the results of the completed phase II efficacy trial in patients with recurrent glioblastoma at the Biotech Showcase(TM) in San Francisco. The presentation will take place on Tuesday, Jan. 14, at 4 p.m. PST at the Parc 55 Wyndham San Francisco - Union Square. "The results of this controlled phase II...